Your browser doesn't support javascript.
loading
Efficacy of guselkumab, a selective IL-23 inhibitor, in Preventing Arthritis in a Multicentre Psoriasis At-Risk cohort (PAMPA): protocol of a randomised, double-blind, placebo controlled multicentre trial.
Haberman, Rebecca H; MacFarlane, Katrina A; Catron, Sydney; Samuels, Jonathan; Blank, Rebecca B; Toprover, Michael; Uddin, Zakwan; Hu, Jiyuan; Castillo, Rochelle; Gong, Cinty; Qian, Kun; Piguet, Vincent; Tausk, Francisco; Yeung, Jensen; Neimann, Andrea L; Gulliver, Wayne; Thiele, Ralf G; Merola, Joseph F; Ogdie, Alexis; Rahman, Proton; Chakravarty, Soumya D; Eder, Lihi; Ritchlin, C T; Scher, Jose U.
Affiliation
  • Haberman RH; Department of Medicine, Division of Rheumatology, New York University Grossman School of Medicine and Psoriatic Arthritis Center, NYU Langone Health, New York, New York, USA.
  • MacFarlane KA; Department of Medicine, Division of Rheumatology, New York University Grossman School of Medicine and Psoriatic Arthritis Center, NYU Langone Health, New York, New York, USA.
  • Catron S; Department of Medicine, Division of Rheumatology, New York University Grossman School of Medicine and Psoriatic Arthritis Center, NYU Langone Health, New York, New York, USA.
  • Samuels J; Department of Medicine, Division of Rheumatology, New York University Grossman School of Medicine and Psoriatic Arthritis Center, NYU Langone Health, New York, New York, USA.
  • Blank RB; Department of Medicine, Division of Rheumatology, New York University Grossman School of Medicine and Psoriatic Arthritis Center, NYU Langone Health, New York, New York, USA.
  • Toprover M; Department of Medicine, Division of Rheumatology, New York University Grossman School of Medicine and Psoriatic Arthritis Center, NYU Langone Health, New York, New York, USA.
  • Uddin Z; Department of Medicine, Division of Rheumatology, New York University Grossman School of Medicine and Psoriatic Arthritis Center, NYU Langone Health, New York, New York, USA.
  • Hu J; Department of Population Health, New York University Grossman School of Medicine, New York, NY, USA.
  • Castillo R; Department of Medicine, Division of Rheumatology, New York University Grossman School of Medicine and Psoriatic Arthritis Center, NYU Langone Health, New York, New York, USA.
  • Gong C; Janssen Scientific Affairs LLC, Horsham, Pennsylvania, USA.
  • Qian K; Department of Population Health, New York University Grossman School of Medicine, New York, NY, USA.
  • Piguet V; University of Toronto, Toronto, Ontario, Canada.
  • Tausk F; Division of Dermatology, Department of Medicine, Women's College Hospital, Toronto, Ontario, Canada.
  • Yeung J; Department of Dermatology, University of Rochester Medical Center, Rochester, New York, USA.
  • Neimann AL; Division of Dermatology, Department of Medicine, Women's College Hospital, Toronto, Ontario, Canada.
  • Gulliver W; Department of Medicine, Division of Rheumatology, New York University Grossman School of Medicine and Psoriatic Arthritis Center, NYU Langone Health, New York, New York, USA.
  • Thiele RG; Department of Dermatology, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada.
  • Merola JF; Department of Medicine, Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center, Rochester, NY, USA.
  • Ogdie A; Harvard Medical School, Boston, Massachusetts, USA.
  • Rahman P; Department of Dermatology/Department of Medicine/Division of Rheumatology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Chakravarty SD; University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Eder L; Department of Medicine, Division of Rheumatology, Memorial University of Newfoundland, St. John's, NL, Canada.
  • Ritchlin CT; Janssen Scientific Affairs LLC, Horsham, Pennsylvania, USA.
  • Scher JU; Drexel University College of Medicine, Philadelphia, Pennsylvania, USA.
BMJ Open ; 12(12): e063650, 2022 12 23.
Article in En | MEDLINE | ID: mdl-36564123

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Arthritis, Psoriatic Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: BMJ Open Year: 2022 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Arthritis, Psoriatic Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: BMJ Open Year: 2022 Type: Article Affiliation country: United States